title: Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
abstract: Mongolia is highly endemic for hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) infections among apparently healthy adults. However, the age-specific prevalence of ongoing HBV, HCV, and HDV infections among children in Mongolia remains unknown. Therefore, samples obtained from a total of 655 apparently healthy children of 0.3-15 years of age (307 boys and 348 girls; age, mean +/- standard deviation [SD], 8.4 +/- 4.2 years) living in Mongolia, between October 2005 and January 2006, were tested for serological and molecular markers of HBV, HCV, and HDV infections. Although 88.7% of the 655 children studied were immunized against hepatitis B, 64 (9.8%) tested positive for hepatitis B surface antigen (HBsAg) and/or HBV DNA and 13 (2.0%) for HDV RNA. Twenty-seven children (4.1%) had detectable HCV RNA. Collectively, 82 (12.5%) were viremic for one or more of these viruses, including eight children with dual viremia of HBV/HCV and one child with triple HBV/HCV/HDV viremia. When children without anti-HBc, anti-HCV and anti-HDV IgG (n = 510) served as a control, a history of hospitalization was significantly associated with HBV viremia (P < 0.0001), anti-HBc positivity (P < 0.0001), and HCV viremia (P = 0.0001). HBsAg mutation was found in 18 (31.6%) of the 57 children with viremia, including those at amino acid position 126, 127, 129, 131, 134, 143 or 144. There were no significant differences in the frequency of HBsAg mutation in relation to age, sex, and hepatitis B vaccination status of the children, suggesting that HBsAg mutation plays a limited role in failure of vaccination in Mongolia.
authors.affiliation: Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Tochigi-Ken, Japan.
authors.forename: Bira
authors.initials: B
authors.lastname: Tsatsralt-Od
authors.forename: Masaharu
authors.initials: M
authors.lastname: Takahashi
authors.forename: Kazunori
authors.initials: K
authors.lastname: Endo
authors.forename: Dondog
authors.initials: D
authors.lastname: Agiimaa
authors.forename: Osorjin
authors.initials: O
authors.lastname: Buyankhuu
authors.forename: Masashi
authors.initials: M
authors.lastname: Ninomiya
authors.forename: Felipe R
authors.initials: FR
authors.lastname: Lorenzo
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Okamoto
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D005838:Genotype; D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000235:genetics; D006526:Hepatitis C / Q000453:epidemiology / Q000517:prevention & control*; D003699:Hepatitis D / Q000453:epidemiology / Q000517:prevention & control*; D003698:Hepatitis Delta Virus; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D008297:Male; D008969:Molecular Sequence Data; D008986:Mongolia / Q000453:epidemiology; D010802:Phylogeny; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D014761:Viral Hepatitis Vaccines